Switch to second-line versus continued first-line antiretroviral therapy for patients with low-level HIV-1 viremia: An open-label randomized controlled trial in Lesotho-Reference-Cited by-同舟云学术

Switch to second-line versus continued first-line antiretroviral therapy for patients with low-level HIV-1 viremia: An open-label randomized controlled trial in Lesotho

Published:2020-09-16 Issue:9 Volume:17 Page:e1003325
ISSN:1549-1676
Container-title:PLOS Medicine
language:en
Short-container-title:PLoS Med

Author:

Amstutz Alain^ORCID,Nsakala Bienvenu Lengo,Vanobberghen Fiona^ORCID,Muhairwe Josephine^ORCID,Glass Tracy Renée,Namane Tilo,Mpholo Tlali,Battegay Manuel,Klimkait Thomas^ORCID,Labhardt Niklaus Daniel^ORCID

Funder

Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung

Publisher

Public Library of Science (PLoS)

Subject

General Medicine

Reference38 articles.

1. European AIDS Clinical Society (EACS). https://www.eacsociety.org/guidelines/eacs-guidelines/eacs-guidelines.html; Guidelines Version 10.0—November 2019.

2. The management of treatment-experienced HIV patients (including virologic failure and switches);J Cutrell;Ther Adv Infect Dis,2020

3. Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study;AJ Rodger;The Lancet,2019

4. Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2018 Recommendations of the International Antiviral Society-USA Panel;MS Saag;JAMA,2018

5. BHIVA guidelines for the routine investigation and monitoring of adult HIV-1-positive individuals 2016 (2019 interim update) [Internet]. [cited 2020 May 8]. Available from: https://www.bhiva.org/monitoring-guidelines

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cabotegravir + Rilpivirine Long-Acting: Overview of Injection Guidance, Injection Site Reactions, and Best Practices for Intramuscular Injection Administration;Open Forum Infectious Diseases;2024-05-25

2. Non-suppressible viraemia during HIV-1 therapy: a challenge for clinicians;The Lancet HIV;2024-05

3. Clinical Relevance of Human Immunodeficiency Virus Low-level Viremia in the Dolutegravir era: Data From the Viral Load Cohort North-East Lesotho (VICONEL);Open Forum Infectious Diseases;2024-01-08

4. Clinical significance and management of low‐level HIV viremia in the era of integrase strand transfer inhibitors;HIV Medicine;2023-11-22

5. Low‐level HIV viraemia during antiretroviral therapy: Longitudinal patterns and predictors of viral suppression;HIV Medicine;2023-09-18